Skip to content

Evaluation of a Psychoeducation Group Program for Mild/Moderate Depression

Evaluation of the Effectiveness and Efficiency of a Psychoeducational Group Sessions Intervention Program in the Depressive Episode Realized by Primary Health Care Center Nurses in Barcelona City.

Status
UNKNOWN
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT00841737
Enrollment
192
Registered
2009-02-11
Start date
2008-01-31
Completion date
2010-04-30
Last updated
2009-08-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Depressive Disorders

Keywords

Depressive Disorders;, Primary Health Care;, Nurses;, Health education.

Brief summary

The purpose of this study is to compare the effectiveness and efficiency of doing a psychoeducational group program and the conventional treatment versus individual conventional care in patients with a mild/moderate depression disorder,in urban primary healthcare centers in Barcelona city.

Detailed description

Nowadays, the depression is one of the public health major issues, this is because of its prevalence and its economic and social repercussions. It is fundamental for the Primary Care to assume the management of these health problems. Design:A randomised controlled trial of two groups (intervention and control), longitudinal and prospective. Population of study: The subjects of the study are patients of 20 to 65 years old attended in 8 urban primary healthcare centers of Barcelona city, identified by the general practitioners and nurses with diagnosis of mild/moderate depression disorder according to the BDI scale. The intervention group receive weekly a psychoeducational group program during 12 weeks run by 2 nurses. The program have a structured content where patient is educated about the illness, pharmacological treatment, the adherence to treatment, diet and physical exercise, problem solving, and cognitive-behavioral therapy. In the control group the depression in treated as usual with the conventional care. Measure's tool: The evolution of patients will be monitoring up to 1 year after the inclusion by a individual interview (the first visit and 3,6 and 9 months).The Beck Depression inventory (BDI) is a self-administered questionnaire that measure the symptomatology and severity of the depression. The analysis variables are: patient's quality of life (EuroQoL-5D scale) ,clinical variables of the patient, pharmacological prescription, anxiolytics and antidepressants consumption , sociodemographic, number of visits to primary healthcare center, number of days of labour lost and cost.

Interventions

The intervention group receive weekly a psychoeducational group during 12 weeks run by 2 nurses. The program have a structures contend.

OTHERControl Group

In the control group the depression is treated as usual with the conventional treatment.

Sponsors

Hospital Universitari Vall d'Hebron Research Institute
CollaboratorOTHER
Centre d'Higiene Mental Les Corts
CollaboratorOTHER
Fundacio d'Investigacio en Atencio Primaria Jordi Gol i Gurina
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
20 Years to 65 Years
Healthy volunteers
No

Inclusion criteria

* Beck Depression Inventory(BDI)\>10 and \<30. * Diagnosis of mild/moderate depressive disorders. * Signed the Informed Consent.

Exclusion criteria

* Patients diagnosed of severe mental psychiatric disorder, * Patients diagnosed of a major depressive disorders, * Patients with acute illness or near-terminal medical illness, * using secondary mental health services, * suicidal ideation or intentions, * don't speak and understand spanish or/and catalan language, * sensory or cognitive disabilities, * illiteracy, * does not know or not give consent to participate in the study, * temporary residents.

Design outcomes

Primary

MeasureTime frame
To measure the symptomatology of the depression by Beck Depression Inventory (BDI) It's a self-administered questionnaire with 21 items (multiple-choice)to measure the intensity, severity and depth of depression.First visit and 3, 6 and 9 months.

Secondary

MeasureTime frame
To measure the patient's quality of life by the EuroQoL questionnaire; number of visits to primary health care center( doctor and nurse); number of days of labour lost; pharmacological prescription; antidepressant and anxiolytics consumption.First visit and 3,6 and 9 months

Countries

Spain

Contacts

Primary ContactRocio Casañas Sánchez, Psychologist
rocio.casanas@chmcorts.com; rcasanas@gencat.cat0034. 695560597

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Mar 24, 2026